Discontinued — last reported Q3 '21
Stryker Medsurg — Segment operating income decreased by 3.6% to $425.00M in Q3 2021 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates improved operational efficiency or higher margins on equipment sales, whereas a decrease suggests rising costs or pricing pressure.
This metric measures the profitability of the MedSurg business segment after deducting direct operating expenses, such a...
Comparable to segment-level operating profit or EBIT reported by major medical technology competitors.
syk_segment_medsurg_segment_operating_income| Q2 '21 | Q3 '21 | |
|---|---|---|
| Value | $441.00M | $425.00M |
| QoQ Change | — | -3.6% |